Related Experiment Video
Updated: May 9, 2026

10:22
Comprehensive Spatial Profiling of Species-agnostic Transcriptomes via Stereo-seq
Published on: October 31, 2025
Single-cell and spatial transcriptomic profiling of POU5F1 in Lung Adenocarcinoma: Dynamics, spatial niche, and
Bingbing Yu1, Meili Zhang1, Haiyong Zhu2
1Department of Pathology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China.
Translational Oncology
|May 7, 2026
Summary
POU5F1 (OCT4) drives lung adenocarcinoma (LUAD) progression by promoting stemness and immune evasion. Targeting POU5F1 offers a promising therapeutic strategy for LUAD patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- POU5F1 (OCT4) is a key pluripotency regulator implicated in tumor stemness and immune microenvironment modulation.
- The specific role and mechanisms of POU5F1 in lung adenocarcinoma (LUAD) remain inadequately understood.
Purpose of the Study:
- To systematically investigate the comprehensive function and underlying mechanisms of POU5F1 in LUAD.
- To evaluate POU5F1 as a potential prognostic biomarker and therapeutic target in LUAD.
Main Methods:
- Integrated genetic causality inference, single-cell and spatial transcriptomics, RNA velocity, and machine learning.
- Summary-based Mendelian Randomization (SMR) linked GWAS with lung tissue eQTL data.
- In vitro experiments validated POU5F1's biological functions, including its effects on proliferation, migration, invasion, and apoptosis.
Main Results:
- POU5F1 showed genetic association with lung cancer risk and was enriched in stem-like LUAD cells.
- Spatial analysis revealed POU5F1+ tumor cells co-localized with cancer-associated fibroblasts (CAFs).
- A POU5F1-related gene signature predicted LUAD prognosis and correlated with immune suppression and targeted therapy response. POU5F1 knockdown inhibited LUAD cell growth and induced apoptosis via the Bcl-2/caspase-3 pathway, EMT modulation, and Nanog downregulation.
Conclusions:
- POU5F1 significantly promotes LUAD progression by sustaining stemness, reprogramming CAFs, and facilitating immune evasion.
- POU5F1 emerges as a potential prognostic biomarker and a promising therapeutic target for LUAD.